Aligned Genetics, Inc. (KOSDAQ: 238120)
South Korea
· Delayed Price · Currency is KRW
3,290.00
-25.00 (-0.75%)
Jan 22, 2025, 3:00 PM KST
Aligned Genetics Revenue
Aligned Genetics had revenue of 3.71B KRW in the quarter ending September 30, 2024, with 1.82% growth. This brings the company's revenue in the last twelve months to 15.00B, up 5.56% year-over-year. In the year 2023, Aligned Genetics had annual revenue of 15.21B with 10.63% growth.
Revenue (ttm)
15.00B
Revenue Growth
+5.56%
P/S Ratio
3.15
Revenue / Employee
227.26M
Employees
66
Market Cap
47.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.21B | 1.46B | 10.63% |
Dec 31, 2022 | 13.75B | 1.99B | 16.92% |
Dec 31, 2021 | 11.76B | 3.80B | 47.82% |
Dec 31, 2020 | 7.96B | 163.45M | 2.10% |
Dec 31, 2019 | 7.79B | 2.12B | 37.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |